Furthermore, GSEA analysis results further indicated that NAP1L5 expression may regulate the development of AML by affecting olfactory signaling pathways, nervous system signaling pathways, apoptotic pathways, and DNA replication pathways (Figure 3C, listed in Supplementary Table S5). The gene discussed is NAP1L5; the disease is acute myeloid leukemia.